Literature DB >> 18193081

N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.

A Ushmorov1, M D Hogarty, X Liu, H Knauss, K M Debatin, C Beltinger.   

Abstract

N-myc has proapoptotic functions, yet it acts as an oncogene in neuroblastoma. Thus, antiapoptotic mechanisms have to be operative in neuroblastoma cells that antagonize the proapoptotic effects of N-myc. We conditionally activated N-myc in SH-EP neuroblastoma cells subjected to the trophic stress of serum or nutrient deprivation while changing the expression of Bcl-2, survivin and FLIP(L), antiapoptotic molecules often overexpressed in poor prognosis neuroblastomas. Bcl-2 protected SH-EP cells from death during nutritional deprivation by activating energetically advantageous oxidative phosphorylation. N-myc overrode the metabolic protection provided by Bcl-2-induced oxidative phosphorylation by reestablishing the glycolytic phenotype and attenuated the antiapoptotic effect of Bcl-2 during metabolic stress. Survivin partially antagonized the growth suppressive function of N-myc in SH-EP neuroblastoma cells during serum deprivation whereas FLIP(L) did not. These findings advance our understanding of the functions of N-myc in neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193081     DOI: 10.1038/sj.onc.1211017

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.

Authors:  Lori S Hart; John T Cunningham; Tatini Datta; Souvik Dey; Feven Tameire; Stacey L Lehman; Bo Qiu; Haiyan Zhang; George Cerniglia; Meixia Bi; Yan Li; Yan Gao; Huayi Liu; Changhong Li; Amit Maity; Andrei Thomas-Tikhonenko; Alexander E Perl; Albert Koong; Serge Y Fuchs; J Alan Diehl; Ian G Mills; Davide Ruggero; Constantinos Koumenis
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

2.  Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth.

Authors:  Ekta Agarwal; Brian J Altman; Jae Ho Seo; Jagadish C Ghosh; Andrew V Kossenkov; Hsin-Yao Tang; Shiv Ram Krishn; Lucia R Languino; Dmitry I Gabrilovich; David W Speicher; Chi V Dang; Dario C Altieri
Journal:  J Biol Chem       Date:  2019-05-16       Impact factor: 5.157

3.  Myc Regulation of a Mitochondrial Trafficking Network Mediates Tumor Cell Invasion and Metastasis.

Authors:  Ekta Agarwal; Brian J Altman; Jae Ho Seo; Irene Bertolini; Jagadish C Ghosh; Amanpreet Kaur; Andrew V Kossenkov; Lucia R Languino; Dmitry I Gabrilovich; David W Speicher; Chi V Dang; Dario C Altieri
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

4.  MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

Authors:  Brian J Altman; Annie L Hsieh; Arjun Sengupta; Saikumari Y Krishnanaiah; Zachary E Stine; Zandra E Walton; Arvin M Gouw; Anand Venkataraman; Bo Li; Pankuri Goraksha-Hicks; Sharon J Diskin; David I Bellovin; M Celeste Simon; Jeffrey C Rathmell; Mitchell A Lazar; John M Maris; Dean W Felsher; John B Hogenesch; Aalim M Weljie; Chi V Dang
Journal:  Cell Metab       Date:  2015-09-17       Impact factor: 27.287

5.  Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.

Authors:  Olesya Chayka; Daisy Corvetta; Michael Dews; Alessandro E Caccamo; Izabela Piotrowska; Giorgia Santilli; Sian Gibson; Neil J Sebire; Nourredine Himoudi; Michael D Hogarty; John Anderson; Saverio Bettuzzi; Andrei Thomas-Tikhonenko; Arturo Sala
Journal:  J Natl Cancer Inst       Date:  2009-04-28       Impact factor: 13.506

6.  Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.

Authors:  Zaowen Chen; Yunfu Lin; Eveline Barbieri; Sue Burlingame; John Hicks; Andrew Ludwig; Jason M Shohet
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

7.  IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers.

Authors:  Hong Xie; Chih-Hang Anthony Tang; Jun H Song; Anthony Mancuso; Juan R Del Valle; Jin Cao; Yan Xiang; Chi V Dang; Roy Lan; Danielle J Sanchez; Brian Keith; Chih-Chi Andrew Hu; M Celeste Simon
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

8.  Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists.

Authors:  Brian J Lestini; Kelly C Goldsmith; Mark N Fluchel; Xueyuan Liu; Niel L Chen; Bella Goyal; Bruce R Pawel; Michael D Hogarty
Journal:  Cancer Biol Ther       Date:  2009-08-08       Impact factor: 4.742

9.  Myc proteins as therapeutic targets.

Authors:  W C Gustafson; W A Weiss
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

10.  Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.

Authors:  Marie-Eve Beaulieu; Toni Jauset; Daniel Massó-Vallés; Sandra Martínez-Martín; Peter Rahl; Loïka Maltais; Mariano F Zacarias-Fluck; Sílvia Casacuberta-Serra; Erika Serrano Del Pozo; Christopher Fiore; Laia Foradada; Virginia Castillo Cano; Meritxell Sánchez-Hervás; Matthew Guenther; Eduardo Romero Sanz; Marta Oteo; Cynthia Tremblay; Génesis Martín; Danny Letourneau; Martin Montagne; Miguel Ángel Morcillo Alonso; Jonathan R Whitfield; Pierre Lavigne; Laura Soucek
Journal:  Sci Transl Med       Date:  2019-03-20       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.